FederalMD
Posted
-
Closes
Oct 21, 2026
Beta-propiolactone Inactivated and Protein Subunit Universal Influenza Vaccine Repeat Dose Toxicity Study
Leidos Biomedical Research, Inc. seeks a qualified vendor to perform FDA-mandated safety analyses of influenza vaccines under solicitation S26-141.